NowDiagnostics, Inc. is a diagnostic technology company that focuses on the development and commercialization of innovative medical testing solutions. The company aims to make accurate and affordable diagnostic tests accessible to everyone, with a particular emphasis on cardiovascular and immune-response testing.

NowDiagnostics, Inc.

NOWDiagnostics® develops and manufactures “Touch to Test” over-the-counter and point of care diagnostic tests that yield results in minutes. Our patented approach allows for virtually any immunological assay to be accurately performed onsite in one step using a tiny amount of capillary blood or in some cases, saliva. We envision a world where people have greater access to in-home testing with in-home results – in minutes. We are committed to changing healthcare by providing accessible, affordable, and accurate testing for all.

NOWDiagnostics | NOWDx

With rates of congenital syphilis skyrocketing since 2018, The Canadian Pediatric Society now recommends 3 syphilis screenings – beginning at the first pregnancy appointment. #nowdx #firsttoknow #syphilis #epidemic #canada #testtotreat

The number of syphilis cases among adults 55+ increased seven-fold between 2012 and 2022, according to the CDC. Nursing homes and retirement communities have created an opportunity for older adults to have new sexual partners. #nowdx #firsttoknow #syphilis #epidemic #testtotreat

Jianghong Qian is our March #employeeofthemonth! Jianghong continues to do an amazing job as Senior Product Development Scientist. You may have noticed we honored her early last year – but she's one of the shining stars on our talented R&D team and we simply couldn't accomplish our goals without her contributions. Well done, Jianghong! #nowdx

The rate of congenital syphilis infections among #nativeamericans (644.7 cases per 100,000 people in 2022) is now comparable to the rate for the entire U.S. population in 1941 – before doctors began using penicillin to cure syphilis. https://bit.ly/49cj58O #nowdx #firsttoknow #syphilis #epidemic 

We’re thrilled to announce that Dr. Stephen Tang, Ph.D., MBA, has been appointed as the Chairman of our Board of Directors. Dr. Tang joins at an exciting time for our company, and we’re delighted to bring his leadership and deep understanding of the diagnostic industry to the #nowdx board. https://bwnews.pr/43ryLDL #chairman #newhire #diagnostics #firsttoknow

COM:NOWDX

NowDiagnostics, Inc.